mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.03 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.03 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.03 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |